Abdominal obesity, impaired nonesterified fatty acid suppression, and insulin-mediated glucose disposal are early metabolic abnormalities in families with premature myocardial infarction

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 7, 1998, Pages 1021-1026

  Kooner, Jaspal S ^a,e   Baliga, Ragavendra R ^a   Wilding, John ^a   Crook, David ^c   Packard, Christopher J ^b   Banks, Linda M ^a   Peart, Stanley ^d   Aitman, Timothy J ^a   Scott, James ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c Wynn Institute   (United Kingdom)

^d ST MARY S HOSPITAL   (United Kingdom)

^e NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Abdominal obesity; Insulin resistance; Myocardial infarction; Nonesterified fatty acids

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL DISEASE; FATTY ACID METABOLISM; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; HEART INFARCTION; HUMAN; INSULIN RESISTANCE; MALE; METABOLIC DISORDER; OBESITY; PRIORITY JOURNAL; RISK;

EID: 0031949842     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.7.1021     Document Type: Article

References (15)

1. Balarajan R. Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales. BMJ. 1991;302:560-564.
2. McKeigue PM, Ferrie JE, Pierpoint T, Marmot MG. Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation. 1993;87:152-161.
3. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
4. Reaven GM, Laws A. Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease. Diabetologia. 1994;37:948-952.
5. Despres JP, Marette A. Relation of components of insulin resistance syndrome to coronary disease risk. Curr Opin Lipidol. 1994;5:274-289.
6. Peters N, Hales CN. Plasma insulin concentrations after myocardial infarction. Lancet. 1965;1:1144-1145.
7. Young MH, Jeng CY, Sheu WH, Shieh SM, Fuh MM, Chen YD, Reaven GM. Insulin resistance, glucose intolerance, hyperinsulinemia and dyslipidemia in patients with angiographically demonstrated coronary artery disease. Am J Cardiol 1994;72:458-460.
8. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 1991;34:416-422.
9. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350-357.
10. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet. 1991;337:382-386.
11. Bhatnagar D, Anand IS, Durrington PN, Patel DJ, Wander GS, Mackness MI, Creed F, Tomenson B, Chandrashekhar Y, Winterbotham M, et al. Coronary risk factors in people from the Indian subcontinent living in West London and their siblings in India. Lancet. 1995;345:405-409.
12. Passmore R, Durnin JVGA. Human energy expenditure. Physiol Rev. 1955;35:801-840.
13. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-E223.
14. Pierson RN Jr, Wang J, Heymsfield SB, Russell-Aulet M, Mazariegos M, Tierney M, Smith R, Thornton JC, Kehayias J, Weber DA, et al. Mea-suring body fat: calibrating the rulers: intermethod comparisons in 389 normal Caucasian subjects. Am J Physiol. 1991;261:E103-E108.
15. Gelding SV, Coldham N, Nithyananthan R, Anyaoku V, Johnston DG. Insulin resistance with respect to lipolysis in non-diabetic relatives of European patients with type 2 diabetes. Diabet Med. 1995;12:66-73.